These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 32497711)
61. Current and emerging drugs for the treatment of pruritus: an update of the literature. Mahmoud RH; Brooks SG; Yosipovitch G Expert Opin Pharmacother; 2024 Apr; 25(6):655-672. PubMed ID: 38682595 [TBL] [Abstract][Full Text] [Related]
62. Emerging drugs for the treatment of chronic pruritic diseases. Fourzali K; Golpanian RS; Yosipovitch G Expert Opin Emerg Drugs; 2020 Sep; 25(3):273-284. PubMed ID: 32715798 [TBL] [Abstract][Full Text] [Related]
63. Atopic itch in dogs: pharmacology and modeling. Olivry T; Bäumer W Handb Exp Pharmacol; 2015; 226():357-69. PubMed ID: 25861789 [TBL] [Abstract][Full Text] [Related]
64. Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: Results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial. Steinke S; Zeidler C; Riepe C; Bruland P; Soto-Rey I; Storck M; Augustin M; Bobko S; Garcovich S; Legat FJ; Lvov A; Misery L; Osada N; Reich A; Şavk E; Serra-Baldrich E; Streit M; Szepietowski JC; Weger W; Dugas M; Ständer S J Am Acad Dermatol; 2018 Sep; 79(3):457-463.e5. PubMed ID: 30119869 [TBL] [Abstract][Full Text] [Related]
65. Interleukin-31 Signaling Bridges the Gap Between Immune Cells, the Nervous System and Epithelial Tissues. Nemmer JM; Kuchner M; Datsi A; Oláh P; Julia V; Raap U; Homey B Front Med (Lausanne); 2021; 8():639097. PubMed ID: 33644104 [TBL] [Abstract][Full Text] [Related]
66. Pathophysiology of pruritus in atopic dermatitis: an overview. Ständer S; Steinhoff M Exp Dermatol; 2002 Feb; 11(1):12-24. PubMed ID: 11952824 [TBL] [Abstract][Full Text] [Related]
67. Itch characteristics in Chinese patients with atopic dermatitis using a new questionnaire for the assessment of pruritus. Yosipovitch G; Goon AT; Wee J; Chan YH; Zucker I; Goh CL Int J Dermatol; 2002 Apr; 41(4):212-6. PubMed ID: 12031029 [TBL] [Abstract][Full Text] [Related]
68. Interleukin-31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge. Hawro T; Saluja R; Weller K; Altrichter S; Metz M; Maurer M Allergy; 2014 Jan; 69(1):113-7. PubMed ID: 24251414 [TBL] [Abstract][Full Text] [Related]
69. Assessing the New and Emerging Treatments for Atopic Dermatitis. Eichenfield LF; Friedlander SF; Simpson EL; Irvine AD Semin Cutan Med Surg; 2016 Jun; 35(5 Suppl):S92-6. PubMed ID: 27525671 [TBL] [Abstract][Full Text] [Related]
70. Update on pruritic mechanisms of hypertrophic scars in postburn patients: the potential role of opioids and their receptors. Cheng B; Liu HW; Fu XB J Burn Care Res; 2011; 32(4):e118-25. PubMed ID: 21747328 [TBL] [Abstract][Full Text] [Related]
76. Is there still a role for UV therapy in itch treatment? Legat FJ Exp Dermatol; 2019 Dec; 28(12):1432-1438. PubMed ID: 31343082 [TBL] [Abstract][Full Text] [Related]
77. Advances in therapeutic strategies for the treatment of pruritus. Stull C; Lavery MJ; Yosipovitch G Expert Opin Pharmacother; 2016; 17(5):671-87. PubMed ID: 26630350 [TBL] [Abstract][Full Text] [Related]
78. Chronic itch: emerging treatments following new research concepts. Misery L; Brenaut E; Pierre O; Le Garrec R; Gouin O; Lebonvallet N; Abasq-Thomas C; Talagas M; Le Gall-Ianotto C; Besner-Morin C; Fluhr JW; Leven C Br J Pharmacol; 2021 Dec; 178(24):4775-4791. PubMed ID: 34463358 [TBL] [Abstract][Full Text] [Related]
79. Itch associated with skin disease: advances in pathophysiology and emerging therapies. Yosipovitch G; Fleischer A Am J Clin Dermatol; 2003; 4(9):617-22. PubMed ID: 12926980 [TBL] [Abstract][Full Text] [Related]
80. Prurigo Nodularis and Its Management. Zeidler C; Yosipovitch G; Ständer S Dermatol Clin; 2018 Jul; 36(3):189-197. PubMed ID: 29929592 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]